Group 1 - The company has established a fair and reasonable pricing policy for its related party transactions, adhering to legal regulations and internal management systems [2] - The related party transactions are executed based on principles of fairness, justice, and equity, ensuring no harm to the company or its shareholders [3] - Previous related party transactions have been executed smoothly without any defaults, indicating the capability of the involved parties to fulfill their obligations [1] Group 2 - The company will hold its first extraordinary general meeting of shareholders in 2026 on January 16, with both on-site and online voting options available [6][7] - The meeting will take place at a specified location in Beijing, and shareholders must register in advance to attend [14] - Specific voting procedures are outlined for shareholders, including the use of the Shanghai Stock Exchange's online voting system [8][9]
北京天坛生物制品股份有限公司